Literature DB >> 17198851

Age-related macular degeneration and risk of coronary heart disease: the Atherosclerosis Risk in Communities Study.

Tien Yin Wong1, Gabriella Tikellis, Cong Sun, Ronald Klein, David J Couper, A Richey Sharrett.   

Abstract

OBJECTIVE: To examine the association of age-related macular degeneration (AMD) with incident coronary heart disease (CHD) and all-cause mortality.
DESIGN: Population-based prospective cohort study. PARTICIPANTS: From the Atherosclerosis Risk in Communities Study (n = 12 536; age range, 49-73 years).
METHODS: Participants had retinal photographs of one eye taken between 1993 and 1995. Photographs were evaluated for the presence of early and late AMD signs according to the Wisconsin grading system. Incident CHD events (acute myocardial infarction, silent myocardial infarction, fatal CHD, and cardiac revascularization procedures) and all-cause mortality were identified prospectively using standardized methods. MAIN OUTCOME MEASURES: Incident CHD events and all-cause mortality.
RESULTS: Of 11,414 persons at risk of CHD, there were 555 (4.9%) with AMD at baseline, of whom 540 were early AMD and 15 were late AMD cases. Over a 10-year follow-up, 922 persons developed an incident CHD event. After controlling for age, gender, race, systolic and diastolic blood pressure, pack-years of cigarette smoking, and other variables, early AMD was not associated with incident CHD (relative risk, 1.08; 95% confidence interval, 0.82-1.42). However, individuals with late AMD were significantly more likely to have an incident CHD event, with 4 CHD events among the 15 participants with late AMD at baseline (10-year cumulative incidence, 30.9%) as compared with 918 CHD events among the 11 399 participants without late AMD (incidence of 10.0%; P = 0.049, Fisher exact test). In the full cohort (n = 12 536), early AMD was not significantly associated with all-cause mortality. However, individuals with late AMD were more likely to die (10-year cumulative mortality rate, 23.5%) than those without late AMD (mortality rate, 8.9%; P = 0.088, Fisher exact test).
CONCLUSIONS: These data provide no evidence of an association between early AMD signs with incident CHD and all-cause mortality in middle-aged persons. Individuals with late AMD appear to have a higher rate of CHD events than those without late AMD, but due to a small number of late AMD cases, this finding should be interpreted cautiously.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17198851     DOI: 10.1016/j.ophtha.2006.06.039

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  39 in total

1.  [Age-related macular degeneration and risk of stroke].

Authors:  V Biousse; M-G Bousser; A Gaudric
Journal:  J Fr Ophtalmol       Date:  2008-01       Impact factor: 0.818

2.  Age-related macular degeneration and mortality in community-dwelling elders: the age, gene/environment susceptibility Reykjavik study.

Authors:  Diana E Fisher; Fridbert Jonasson; Gudny Eiriksdottir; Sigurdur Sigurdsson; Ronald Klein; Lenore J Launer; Vilmundur Gudnason; Mary Frances Cotch
Journal:  Ophthalmology       Date:  2014-09-26       Impact factor: 12.079

3.  Age-related macular degeneration and mortality in older women: the study of osteoporotic fractures.

Authors:  Kathryn L Pedula; Anne L Coleman; Fei Yu; Jane A Cauley; Kristine E Ensrud; Marc C Hochberg; Howard A Fink; Teresa A Hillier
Journal:  J Am Geriatr Soc       Date:  2015-05-04       Impact factor: 5.562

4.  Mortality associated with bevacizumab intravitreal injections in age-related macular degeneration patients after acute myocardial infarct: a retrospective population-based survival analysis.

Authors:  Joel Hanhart; Doron S Comaneshter; Yossi Freier-Dror; Shlomo Vinker
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-02-10       Impact factor: 3.117

5.  Coronary Artery Disease and Reticular Macular Disease, a Subphenotype of Early Age-Related Macular Degeneration.

Authors:  Rachel M Cymerman; Adam H Skolnick; William J Cole; Camellia Nabati; Christine A Curcio; R Theodore Smith
Journal:  Curr Eye Res       Date:  2016-05-09       Impact factor: 2.424

6.  Age-related macular degeneration and mortality: the Melbourne Collaborative Cohort Study.

Authors:  M B McGuinness; R P Finger; A Karahalios; R H Guymer; D R English; E W Chong; A M Hodge; L D Robman; G G Giles; J A Simpson
Journal:  Eye (Lond)       Date:  2017-08-18       Impact factor: 3.775

Review 7.  Anti-VEGF therapies and blood pressure: more than meets the eye.

Authors:  Frank Enseleit; Stephan Michels; Frank Ruschitzka
Journal:  Curr Hypertens Rep       Date:  2010-02       Impact factor: 5.369

8.  Age-related macular degeneration and incident cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Antonio B Fernandez; Tien Y Wong; Ronald Klein; Dorothea Collins; Gregory Burke; Mary Frances Cotch; Barbara Klein; Mehran M Sadeghi; Jersey Chen
Journal:  Ophthalmology       Date:  2011-12-23       Impact factor: 12.079

Review 9.  Intravitreal Bevacizumab and Cardiovascular Risk in Patients with Age-Related Macular Degeneration: Systematic Review and Meta-Analysis of Randomized Controlled Trials and Observational Studies.

Authors:  Ivana Mikačić; Damir Bosnar
Journal:  Drug Saf       Date:  2016-06       Impact factor: 5.606

10.  Age-Related Macular Degeneration and Coronary Artery Disease in a VA Population.

Authors:  Joseph Thomas; Sohail Mohammad; Richard Charnigo; Judit Baffi; Ahmed Abdel-Latif; Khaled M Ziada
Journal:  South Med J       Date:  2015-08       Impact factor: 0.954

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.